Tuberculosis vaccine: How a pharma giant prioritised billions in profit over developing the shot

Tuberculosis remains a ‘poor’ disease that mostly afflicts those living in developing countries.

Related Keywords

South Africa , Chile , Philadelphia , Pennsylvania , United States , National Institutes Of Health , Maryland , Netherlands , United Kingdom , Buenos Aires , Distrito Federal , Argentina , Brazil , Rockville , Montana , Thailand , Australia , Chilean , America , South African , Thomas Scriba , Tom Evans , Wolfgang Leitner , Mike Frick , Neil Martinson , Paul Sagan , Steven Reed , Julio Croda , Luc Debruyne , Jeremy Farrar , Smithkline Beckman , Glenda Gray , Emma Walmsley , Wikimedia Commons , Carl Alving , Thomas Breuer , Treatment Action Group , Tb Vaccine Accelerator Council , Tuberculosis Research Section , Reuters , Walter Reed Army Institute Of Research , Drug Administration , National Institute Of Allergy , Melinda Gates Foundation , National Institute Of Health , Laboratory Of Clinical Immunology Microbiology , Us Army , Department Of Veterans Affairs , Gates Foundation , Melinda Gates Medical Research Institute , Cornell University , Wellcome , World Health Organization , Big Pharma , Melinda Gates Medical Research , Walter Reed Army Institute , Veterans Affairs , National Institutes , Clinical Immunology , Michel De Wilde , National Institute , World Health , Wellcome Trust , South America , Eastern Europe , Accelerator Council , Walter Reed Army , Infectious Diseases , Treatment Action , Health , Sk Tb Vaccine , S Therea Tb Vaccine , S Therea Tb Vaccine For Adults , Roblems With Big Pharma , Hat 39s Wrong With Big Pharma , Iggest Problems With Big Pharma , B Vaccine History , Isease Disparities ,